The downgrade is based on Torrid Holdings' disappointing Q1 results, with sales and gross margin falling short of consensus forecasts. Additionally, the company has experienced significant management turnover in the past year, which may require more time to stabilize the business. The analyst also cites a lack of visibility around consumer health as a reason for the downgrade. These factors are likely to negatively impact the stock price in the short term.